There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > IL-8


Brief Information

Target Synonym:IL8/NAP1 form VI,T-cell chemotactic factor,GCP/IL-8 protein III,IL8/NAP1 form II,GCP/IL-8 protein II,(Ala-IL-8)77,Emoctakin,IL8/NAP1 form IV,LYNAP,IL8/NAP1 form III,IL8/NAP1 form V,GCP/IL-8 protein I,Neutrophil-Activating Peptide 1,Interleukin 8,GCP-1,MDN
Number of Launched Drugs:1
Number of Drugs in Clinical Trials:7
Lastest Research Phase:Approved

Product ListCompare or Buy

Part of Bioactivity data

Cynomolgus IL-8, His TagCynomolgus IL-8, His Tag (Cat. No. IL8-C52H3) ELISA bioactivity

Immobilized Cynomolgus IL-8, His Tag (Cat. No. IL8-C52H3) at 1 μg/mL (100 μL/well) can bind Monoclonal Anti-Human IL-8 Antibody, Human IgG1 with a linear range of 0.1-2 ng/mL (QC tested).

Biotinylated Human IL-8, His,AvitagBiotinylated Human IL-8, His,Avitag (Cat. No. IL8-H82H3) ELISA bioactivity

Immobilized Biotinylated Human IL-8, His,Avitag (Cat. No. IL8-H82H3) at 1 μg/mL (100 μL/well) on streptavidin precoated (0.5 μg/well) plate can bind Monoclonal Anti-Human IL-8 Antibody, Human IgG1 with a linear range of 0.06-2 ng/mL (QC tested).

Synonym Name



Interleukin 8 (IL8 or chemokine (C-X-C motif) ligand 8, CXCL8) is a chemokine produced by macrophages and other cell types such as epithelial cells, airway smooth muscle cells and endothelial cells. There are many receptors on the surface membrane capable of binding IL-8, the most frequently studied types are the G protein-coupled serpentine receptors CXCR1 and CXCR2. Expression and affinity for IL-8 differs between the two receptors (CXCR1 > CXCR2). IL-8(6-77) has a 5-10-fold higher activity on neutrophil activation, IL-8(5-77) has increased activity on neutrophil activation and IL-8(7-77) has a higher affinity to receptors CXCR1 and CXCR2 as compared to IL-8(1-77), respectively.

Clinical and Translational Updates

Public Drug Information

Name Research Code Research Phase Company First Brand Name First Approved Country First Indication First Approved Company First Approved Date Indications Clinical Trials
Mouse monoclonal antibody against human interleukin-8 cream Approved Dalian Yawei Pharmaceutical Co Ltd, Dongguan Hongyuan Yishi Biotechnology Pharmaceutical Co Ltd 恩博克 Mainland China Eczema; Psoriasis Dalian Asia Space Pharmaceutical Co Ltd 2001-04-10 Psoriasis; Eczema Details

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
PXL-01 PXL-01 Phase 3 Clinical Promore Pharma Tissue Adhesions; Post-surgical adhesions Details
AC-701 AC-701 Phase 2 Clinical Twi Pharmaceuticals Inc Rosacea; Exanthema Details
Cis-urocanic acid Cis-UCA; UCA-001; UCA-002 Phase 2 Clinical Herantis Pharma Dry Eye Syndromes; Urinary Bladder Neoplasms; Xerophthalmia; Dermatitis, Atopic Details
HuMax-IL8 MDX-018; BMS-986253 Phase 2 Clinical Medarex, Genmab, Bristol-Myers Squibb Company Liver Neoplasms; Neoplasms; Carcinoma, Non-Small-Cell Lung Details
HL-2351 GX-P4; HL-2351; rhIL-1Ra-hyFc Phase 1 Clinical Genexine Inc Arthritis, Rheumatoid; Cryopyrin-Associated Periodic Syndromes Details

This web search service is supported by Google Inc.